Latest gene delivery Stories
Leading gene therapy Company will partner with established market leader to develop a potential new treatment paradigm for hemophilia B PHILADELPHIA, Dec.
New research from a team of European scientists has shown that genetic material is capable of surviving both the hostile environment of suborbital space and the violent passage through Earth’s atmosphere at a high rate of speed.
Dr. Daniel M. Takefman brings 15 years of FDA experience to leading gene therapy company PHILADELPHIA, Nov.
A new stem cell gene therapy is set to begin clinical trials early next year after the technique reportedly cured 18 children who were born without working immune systems due to a condition known as “Bubble Baby” disease.
Dr. Mitchell Gaynor, acclaimed M.D.
Company on track to report Phase 3 data in second half of 2015 PHILADELPHIA, Nov.
LAS VEGAS, Sept.
GREENWICH, Conn., Aug.
BERGISCH GLADBACH, Germany, August 14, 2014 /PRNewswire/ -- Addition of lentiviral gene delivery capabilities complements strategic partnering portfolio.
- A pivoted catch designed to fall into a notch on a ratchet wheel so as to allow movement in only one direction (e.g. on a windlass or in a clock mechanism), or alternatively to move the wheel in one direction.